文献速递主动脉疾病

破裂腹主动脉瘤腔内与开放修复术后10年随访的个体患者数据Meta分析

Individual Patient Data Meta-Analysis of 10-Year Follow-Up after Endovascular and Open Repair for Ruptured Abdominal AorticAneurysms.
PubMed 文献 · Ann Vasc Surg · 2023-01-21

该个体患者数据Meta分析纳入21项研究共12187例破裂腹主动脉瘤患者(EVAR 4952例,OSR 7235例),比较两种修复方式的长期生存。全部研究中EVAR中位生存4.20年、OSR 1.91年,10年随访时EVAR限制性平均生存时间(RMST)较OSR多0.54年(95%CI 0.35-0.73;P<0.001);仅3项RCT的个体患者数据Meta分析未显示显著差异。作者认为严格随访方案是可取的,尤其对预期寿命长的患者。

要点

  • 全部研究中EVAR中位生存4.20年(95%CI 3.70-4.58),OSR为1.91年(95%CI 1.57-2.39)。
  • 10年随访时EVAR的RMST较OSR多0.54年(95%CI 0.35-0.73;P<0.001)。
  • 仅3项RCT的个体患者数据Meta分析未显示显著差异。

核心结论

  • 分析全部符合条件的研究后,10年随访时EVAR较OSR的预期寿命增加6.5个月。
  • 作者认为严格随访方案是可取的,尤其对预期寿命长的患者。

研究设计与样本

  • 研究类型为时间-事件个体患者数据Meta分析,纳入所有比较破裂腹主动脉瘤EVAR与OSR术后死亡率的研究。
  • 共21项研究、12187例患者(EVAR 4952例,OSR 7235例)最终 deemed eligible。
  • 二次个体患者数据分析仅纳入3项RCT的725例患者(EVAR 372例,OSR 353例),RCT为Immediate Management of the Patient With Rupture: Open Versus Endovascular Repair、Endovasculaire ou Chirurgie dans les Anévrysmes aorto-iliaques Rompus和Amsterdam Acute Aneurysm Trial。
  • 采用限制性平均生存时间(RMST)作为EVAR与OSR预期寿命的度量指标。

主要发现

  • 全部研究中EVAR中位生存4.20年(95%CI 3.70-4.58),OSR中位生存1.91年(95%CI 1.57-2.39)。
  • EVAR在术后4至7年风险增加,于术后6年达峰。
  • 10年随访结束时EVAR的RMST较OSR多0.54年(95%CI 0.35-0.73;P<0.001)。
  • 仅3项RCT的个体患者数据Meta分析未显示显著差异。

临床怎么用

  • 作者认为严格随访方案是可取的,尤其对预期寿命长的患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endovascular aortic repair (EVAR) has conferred an early survival advantage compared to an open surgical repair (OSR) in patients with ruptured abdominal aortic aneurysms (rAAA). However, the long-term survival benefit after EVAR was not displayed among randomized controlled trials (RCTs), whereas many non-RCTs have provided conflicting results. We conducted a time-to-event individual patient data (IPD) meta-analysis on long-term rAAA data. METHODS: All studies comparing mortality after EVAR versus OSR for rAAA were included. We used restricted mean survival times (RMSTs) as a measure of life expectancy for EVAR and OSR. RESULTS: A total of 21 studies, including 12,187 patients (4952 EVAR and 7235 OSR) were finally deemed eligible. A secondary IPD analysis included 725 (372 EVAR and 353 OSR) patients only from the 3 RCTs (Immediate Management of the Patient With Rupture : Open Versus Endovascular Repair, Endovasculaire ou Chirurgie dans les Anévrysmes aorto-iliaques Rompus and Amsterdam Acute Aneurysm Trial trials). Among all studies, the median survival was 4.20 (95% confidence interval [CI]: 3.70-4.58) years for EVAR and 1.91 (95% CI: 1.57-2.39) years for OSR. Although EVAR presented with increased hazard risk from 4 to 7 years, which peaked at 6 years after the operation, the RMST difference was 0.54 (95% CI: 0.35-0.73; P < 0.001) years gained with EVAR at the end of the 10-year follow-up. IPD meta-analysis of RCTs did not demonstrate significant differences. CONCLUSIONS: At 10-years follow-up, EVAR was associated with a 6.5 month increase in life expectancy when compared to OSR after analyzing all eligible studies. Evidence from our study suggests that a strict follow-up program would be desirable, especially for patients with long-life expectancy.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Antonopoulos CN, Moulakakis KG, Rorris FP, et al. Individual Patient Data Meta-Analysis of 10-Year Follow-Up after Endovascular and Open Repair for Ruptured Abdominal AorticAneurysms. Ann Vasc Surg. 2023. PMID: 36690248. doi:10.1016/j.avsg.2023.01.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。